ANNOUNCES THE USE OF A VIRTUAL PLATFORM TO RECRUIT COVID-19 PATIENTS IN CANADA TO THE PHASE 2 TRIAL. WILL ALSO ASSESS THE IMPACT OF OMEGO ON HOSPITALISED PATIENTS WITH SEVERE FORMS OF COVID-19 IN MEXICO AND BRAZIL

SHARE CAPITAL INCREASE REGISTERED

New study highlights the potential of OmeGo® as a prophylactic therapy for Asthma and COPD

ISSUANCE OF NEW SHARES FOLLOWING EXERCISE OF OPTIONS – PRIMARY INSIDER DISCLOSURE

SECOND QUARTER & HALF YEAR 2020 FINANCIAL REPORT

SECURES DISTRIBUTION WITH A GLOBAL RETAILER GIANT IN THE UK, SPAIN, ICELAND, AND ONLINE FOR BRILLIANT SALMON OIL™ FOR PETS

HBC AQUIRES A 34 PERCENT STAKE IN HEALTHCARE AND PETCARE DISTRIBUTOR ATLANTIC DELIGHTS LTD FOR ACCESS TO CHINESE MARKET

STRENGTHENS R&D FUNCTION WITH THE HIRING OF DR. ERLAND HERMANSEN AS MEDICAL DIRECTOR FOR CLINICAL DEVELOPMENT

CORRECTION: SHARE CAPITAL DECREASE REGISTERED – NEW PAR VALUE

SHARE CAPITAL DECREASE REGISTERED – NEW PAR VALUE